Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors

Open access
Esposito, Francesca, Tramontano, Enzo · 2014 · Antiviral Chemistry and Chemotherapy

Abstract

Catalytic HIV type-1 (HIV-1) integrase (IN) and ribonuclease H (RNase H) domains belong to the polynucleotidyl transferase superfamily and are characterized by highly conserved motifs that coordinate two divalent Mg 2+ cations and are attractive targets for new antiviral agents. Several structural features of both domains are now available. Drugs targeting the HIV-1 IN are currently approved for anti-HIV therapy, while no drug targeting the HIV-1 RNase H function is yet available. This review describes HIV-1 IN and the RNase H function and structures, compounds targeting their active sites and dual inhibition as a new approach for drug development.

Overview

Integrity signals

Registry

Crossref · 10.3851/imp2690

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 109 · Cited by 68

Research works printed but not linked: 2

  1. Billich A, 2003, Curr Opin Investig Drugs, 4, 206
  2. Fantauzzi A, 2013, HIV AIDS (Auckl), 5, 29

Metadata

Authors
Esposito, F., & Tramontano, E.
Affiliations
University of Cagliari (IT)
Venue
Antiviral Chemistry and Chemotherapy
Published
2014-08
Volume
23
Issue
4
Pages
129-144
ISSN
  • 0956-3202 (ISSN-L)
  • 2040-2066
OpenAlex
W2003586359
Cited by
68
References
109
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 5 · 2016: 9 · 2015: 5 · 2014: 6
FWCI
1.00
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Antiviral chemistry & chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
HIV-1 integrase, RNase H, HIV-1 reverse transcriptase, integrase inhibitors, RNase H inhibitors, antiviral drug discovery, Mg2+ coordination, protein structure
MeSH terms
Humans, Models, Molecular, HIV-1, HIV Infections, Ribonuclease H, HIV Integrase, HIV Integrase Inhibitors, Catalytic Domain, HIV Reverse Transcriptase, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors. https://app.cochat.ai/papers/10.3851/imp2690
The paper
Esposito, F., & Tramontano, E. (2014). Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors. Antiviral Chemistry and Chemotherapy. https://doi.org/10.3851/imp2690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.